Skip to main content

Table 2 Comparison of choroidal thickness between patients with neovascular age-related macular degeneration and age-matched controls

From: Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration

  AMD group Control group P value*
(n = 39) (n = 39)
Subfoveal CT (μm) 228.6 ± 78.6 224.2 ± 54.7 0.775
Peripapillary CT (μm)
 Mean 153.2 ± 45.3 148.2 ± 38.8 0.600
 Superior 165.2 ± 49.5 160.3 ± 42.6 0.637
 Nasal 153.2 ± 43.0 148.3 ± 36.5 0.591
 Inferior 127.3 ± 40.0 122.7 ± 32.5 0.577
 Temporal 167.1 ± 54.5 161.4 ± 49.8 0.635
  1. Continuous variables are expressed as mean ± standard deviation
  2. *Comparison of baseline parameters between the control group and AMD group, P value was based on the student t-test
  3. AMD age-related macular degeneration, CT choroidal thickness